# Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis

> **NCT01202500** · PHASE3 · TERMINATED · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 302 (actual)

## Conditions studied

- Congenital Toxoplasmosis

## Interventions

- **PROCEDURE:** reducing treatment to 3 months
- **PROCEDURE:** registered length of treatment

## Key facts

- **NCT ID:** NCT01202500
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07-28
- **Primary completion:** 2017-01-26
- **Final completion:** 2022-04-07
- **Target enrollment:** 302 (ACTUAL)
- **Why stopped:** Fansidar marketing discontinued
- **Last updated:** 2024-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01202500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01202500, "Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01202500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*